A Pilot Trial of N-803: Patients With Synovial Sarcoma and Myxoid/Round Cell Liposarcoma Previously Treated With Adoptive Cellular Therapy
ONCOLOGY · 28.10.2026 · 40 (7)
DOI: 10.46883/2026.25921246 ↗Kurz gefasst
Fachartikel in der Zeitschrift ONCOLOGY, online erschienen am 28.10.2026. Verfasst von Daphne P Edgren Bfa und 2 weiteren Autor:innen. Hauptthemen laut MEDLINE: Immunotherapy, Adoptive, Interleukin-15, Liposarcoma, Myxoid, Sarcoma, Synovial. Die Arbeit nennt 21 Literaturangaben.
Abstract (Originalsprache)
A pilot early phase 1 trial (NCT07261657) represents the first clinical effort to activate persisting transferred rare persisting cells by using IL-15 superagonist N-803.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Zitieren
APA
Daphne P Edgren Bfa, Pedro Viveiros Md, & Pollack, S. M. (2026). A Pilot Trial of N-803: Patients With Synovial Sarcoma and Myxoid/Round Cell Liposarcoma Previously Treated With Adoptive Cellular Therapy. ONCOLOGY, 40(7). https://doi.org/10.46883/2026.25921246
Vancouver
Daphne P Edgren Bfa, Pedro Viveiros Md, Pollack SM. A Pilot Trial of N-803: Patients With Synovial Sarcoma and Myxoid/Round Cell Liposarcoma Previously Treated With Adoptive Cellular Therapy. ONCOLOGY. 2026;40(7). doi:10.46883/2026.25921246
BibTeX
@article{DaphnePEdgrenBfa2026,
author = {Daphne P Edgren Bfa and Pedro Viveiros Md and Pollack, Seth M},
title = {A Pilot Trial of N-803: Patients With Synovial Sarcoma and Myxoid/Round Cell Liposarcoma Previously Treated With Adoptive Cellular Therapy},
journal = {ONCOLOGY},
year = {2026},
volume = {40},
number = {7},
doi = {10.46883/2026.25921246}
}
EUVIMED